NewsRoom Articles - Page 159 of 600

MondaySep 19, 2022 4:20 am

420 with CNW — Germany Is Importing More Medical Cannabis from Sources Closer to Home

During the first half of 2022, Germany imported a high amount of cannabis for scientific use and medical sales. Last year, the country cumulatively imported more than 20,500 kg of marijuana for scientific and medical purposes. This figure is significantly higher than its 2020 figure of 13,345 kg. In 2019, the country imported a little more than 8,000 kilograms of cannabis. Data from the Federal Institute for Drugs and Medical Devices shows that through the first half of the year, imports of dried flower and extracts increased by more than 6% to reach 10,486 kilograms. This is in comparison to…

FridaySep 16, 2022 4:20 pm

420 with CNW — Innovative Packaging Could Give Cannabis Brands a Competitive Edge

Cannabis is one of the fastest-growing industries in America. Just two decades after California first legalized medical and recreational cannabis, the industry has created hundreds of thousands of jobs and generates billions of dollars in sales revenue every year. Experts believe the cannabis space will become even more profitable as more states launch legal cannabis markets, predicting it will be worth a whopping $197.74 billion in 2028. Naturally, such mouth-watering profits have attracted numerous companies to the cannabis sector, with new organizations entering the space every year. Companies that want to stand out among the crowd and consistently attract customers…

FridaySep 16, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), Growing its Market Share, One Patent at a Time

Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European Union, Japan, India and Mexico with approximately 50 additional patents pending around the world Its latest patent, granted in Mexico, applies a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a variety of ready-to-drink consumer retail beverage products Lexaria remains committed to advancing its research and expanding the indications and efficacy of its DehydraTECH technology, as it looks to benefit from the CBD industry, projected to be valued at $111.8 billion by 2030, and…

FridaySep 16, 2022 4:20 am

420 with CNW — Missouri Court Dismisses Suit Against Cannabis Ballot Initiative

Cannabis reform activists in Missouri received a reprieve after a state court dismissed a lawsuit against a ballot initiative that seeks to legalize cannabis in Missouri and facilitate the expungement of nonviolent cannabis-related charges. Soon after a cannabis reform initiative by Legal Missouri 2022 received state certification, prohibitionists filed a lawsuit asking that the initiative be dismissed. With the backing of Protect Our Kids PAC, Community Anti-Drugs Coalitions of America (CADCA) member Joy Sweeney filed a suit against the cannabis ballot initiative. Her suit claimed that the measure was not in line with single-subject rules for ballot measures as per…

ThursdaySep 15, 2022 4:20 pm

420 with CNW — White House Reveals President Biden Has No Plans to Act on Cannabis Reform Ahead of Midterms

Last week, the White House suggested that President Joe Biden would not be making any cannabis policy moves ahead of the midterms. When asked about whether Biden would discuss cannabis before the election, Karine Jean-Pierre, the administration’s press secretary, acknowledged that questions on the president’s plans for marijuana policy had come up on numerous occasions in press briefings. Jean-Pierre reiterated that the president’s position on marijuana remained the same: leave the adult-use legalization of cannabis to the states, reschedule the plant, federally decriminalize it and expunge previous records. This is in addition to explaining that President Biden believed that there…

ThursdaySep 15, 2022 4:20 am

420 with CNW — King’s College London Plans Largest Study on Marijuana

Over the past two decades, research into the potential benefits and risks of cannabis has revealed that the plant has lots of potential as a treatment for conditions such as chronic pain, insomnia and anxiety disorders. Although cannabis research is still in its infancy, partly because federal prohibition prevented scientists from studying the plant for a long time, preliminary results have been so encouraging that dozens of American states as well as several countries around the world have legalized medical cannabis use. Most experts still acknowledge that we need to research cannabis more extensively. There is little data on how…

WednesdaySep 14, 2022 4:20 pm

420 with CNW — California Cannabis Authority Enters Partnership with CPPC

California was the first state to legalize medical and recreational cannabis use in America. More than two decades later, the Golden State boasts the largest cannabis industry in the country with hundreds of licensed cannabis businesses generating billions of dollars in cannabis sales. The California Cannabis Authority (CCA), which is in charge of regulating California’s mammoth cannabis sector, recently announced that it has entered a partnership with Cannabis Public Policy Consulting (CPPC). The partnership is expected to bring super-advanced data analytics, comprehensive and up-to-date data sets as well as expert consulting to cannabis regulators in the state. CPPC director Mackenzie…

WednesdaySep 14, 2022 11:00 am

American Cannabis Partners Committed to Implementing Key Sustainable Operating Practices

Forbes reports that “sustainability is increasingly becoming a necessity for corporations due to changing perspectives around the world” Unfortunately, while 90% of executives think sustainability is important, only 60% of companies have a sustainability strategy ACP’s sustainable operating practices appear ideally aligned with today’s expectations With a focus on sustainability becoming increasingly essential for companies to succeed in today’s market, American Cannabis Partners (“ACP”) has made its sustainable operating practices a top priority. The company is “contending for first place in the U.S. cannabis industry through proven strategies that continue to accelerate ACP in assets, operations, expansions and market share” (https://acpfarms.com).…

WednesdaySep 14, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Strengthens Board of Directors to Boost Efforts toward Regulatory Approval of Potential Treatment for Hypertension

Lexaria Bioscience is a global innovator in drug delivery platforms whose lead technology, DehydraTECH, has been shown to increase the bioavailability of APIs The company recently announced that Catherine Turkel, PharmD, Ph.D., has joined its board of directors Dr. Turkel, who brings over 20 years’ experience, has previously formulated Food and Drug Administration (“FDA”) registration and commercial strategic plans, as well as led global development programs for pharmaceutical and biologic treatments Dr. Turkel will lend her drug registration experience and regulatory expertise to Lexaria at a time when the company is journeying toward regulatory approval for DehydraTECH-CBD, its drug candidate…

WednesdaySep 14, 2022 4:20 am

420 with CNW — Study Says Pharma Industry Loses Billions as Cannabis Legalization Spreads

Over the past two or so decades, a growing body of scientific research has proved that cannabis has the potential to treat a variety of medical conditions. Even though federal law classifies cannabis as a Schedule I controlled substance with no medical applications, studies have found that the drug can be effective against inflammation, anxiety disorders, chronic pain and high blood pressure, among other things. As people become more cognizant of the short- and long-term side effects of using pharmaceutical medications, “safer” alternatives such as cannabis have grown increasingly popular. Dozens of states now allow their residents to purchase and…